AS Latvijas Juras medicinas centrs Capital Reinvestment Ratio
AS Latvijas Juras medicinas centrs capital reinvestment ratio. AS Latvijas Juras medicinas centrs (UOM) has a Capital Reinvestment Ratio of 0.91x as of September 2025, meaning it reinvests 1% of its operating cash flow (€474.45K) in capital expenditures (€430.89K). Check UOM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AS Latvijas Juras medicinas centrs (2015–2024)
Capital reinvestment ratio of AS Latvijas Juras medicinas centrs from 2015 to 2024. This chart tracks AS Latvijas Juras medicinas centrs's Capital Reinvestment Ratio across 10 annual periods. Also explore UOM net asset momentum to track the company's year-over-year net asset growth rate.
AS Latvijas Juras medicinas centrs Capital Reinvestment Ratio by Year (2015–2024)
AS Latvijas Juras medicinas centrs capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see UOM cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.72x | €605.02K | €436.21K | ▼ -44.4% |
| 2023 | 1.30x | €1.91 Million | €2.48 Million | ▲ +125.1% |
| 2022 | 0.58x | €1.09 Million | €629.72K | ▼ -78.3% |
| 2021 | 2.65x | €418.24K | €1.11 Million | ▲ +277.5% |
| 2020 | 0.70x | €732.71K | €515.12K | ▲ +52.6% |
| 2019 | 0.46x | €412.86K | €190.16K | ▲ +219.4% |
| 2018 | 0.14x | €599.57K | €86.45K | ▼ -88.6% |
| 2017 | 1.27x | €478.41K | €605.51K | ▼ -38.4% |
| 2016 | 2.06x | €418.49K | €860.13K | ▲ +186.4% |
| 2015 | 0.72x | €362.36K | €260.06K | — |